Choose Your Country or Region

CaMK

Isoform-selective Products

CaMKII CaMKIII CaMKKα CaMKKβ PKD

CaMK Products

All (20)
CaMK Inhibitors (12)
CaMK Activator (1)
CaMK Modulators (2)
New CaMK Products

Catalog No.	Product Name	Information	Product Use Citations
S1421	Staurosporine (STS)	Staurosporine (STS) is a potent PKC inhibitor for PKCα, PKCγ and PKCη with IC50 of 2 nM, 5 nM and 4 nM, less potent to PKCδ (20 nM), PKCε (73 nM) and little active to PKCζ (1086 nM) in cell-free assays. Also shows inhibitory activities on other kinases, such as PKA, PKG, S6K, CaMKII, etc. Phase 3.	Cell Metab, 2025, S1550-4131(25)00149-4 Genes Dis, 2025, 12(3):101321 Cells, 2025, 14(6)450
S7423	KN-93 Phosphate	KN-93 Phosphate is a potent and specific inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) with K_i of 0.37 μM, no remarkable inhibitory effects on APK, PKC, MLCK or Ca2+-PDE activities. KN-93 attenuates CaMKII-induced autophagy.This product is not soluble in saline. Please do not dissolve it in saline for administration.	Stem Cell Res Ther, 2025, 16(1):208 bioRxiv, 2025, 2025.03.20.644192 Eye Vis (Lond), 2024, 11(1):37
S6787	KN-93	KN-93 is a cell-permeable, reversible and competitive inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMK-II) with Ki of 2.58 μM at rabbit myocardial CaM kinase activity.	Acta Neuropathol Commun, 2025, 13(1):70 Nat Commun, 2024, 15(1):840 Nat Commun, 2024, 15(1):1300
S7422	KN-62	KN-62 is a potent and specific inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) with Ki of 0.9 μM; also a non-competitive antagonist of the purinergic receptor P2RX7 (IC50 = 15 nM). It is selective for CaMKII relative to PKA, PKC and MLCK, but inhibits CaMKI and CaMKIV equally well, The Ki value of KN-62 for CaMK V is 0.8 μM.	Redox Biol, 2024, 75:103249 Int J Mol Sci, 2024, 25(8)4340 Cell Rep, 2023, 42(7):112696
S8274	STO-609	STO-609 is a specific inhibitor of the Ca2+/Calmodulin-dependent protein kinase kinase(CaM-KK) that inhibits the activities of recombinant CaM-KKα and CaM-KKβ isoforms, with Ki values of 80 and 15 ng/ml, respectively, and also inhibits their autophosphorylation activities. STO-609 inhibits AMPKK activity and inhibits autophagy.	Redox Rep, 2025, 30(1):2447721 Cell Genom, 2025, 5(3):100782 Acta Pharm Sin B, 2024, 14(8):3576-3590
S7188	CID755673	CID755673 is a cell-active pan-PKD1/2/3 inhibitor with IC50 of 180 nM, 280nM, and 227 nM, respectively, about 200-fold selectivity over other CAMKs.	J Thromb Haemost, 2024, S1538-7836(24)00618-4 Nat Commun, 2023, 14(1):3543 Nat Commun, 2023, 14(1):3543
S9141	Berbamine	Berbamine (BA), a traditional Chinese medicines extracted from Berberis amurensis (xiaoboan), is a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity and also an inhibitor of NF-κB. Berbamine (BA) induces apoptosis in human myeloma cells and inhibits the growth of cancer cells by targeting Ca²⁺/calmodulin-dependent protein kinase II (CaMKII).	Vet Res, 2025, 56(1):37 Vet Microbiol, 2025, 301:110356 iScience, 2024, 27(10):110862
S7436	NH125	NH125 is a selective eEF-2 kinase inhibitor with IC50 of 60 nM, >125-fold selectivity over PKC, PKA, and CaMKII, and also a potent histidine kinase inhibitor.	Acta Pharmacol Sin, 2018, 10.1038/s41401-018-0165-9 Drug Des Devel Ther, 2018, Drug Des Devel Ther BMC Cancer, 2016, 16(1):813
S6507	KN-92 phosphate	KN-92 is an inactive derivative of KN-93, the selective inhibitor of Ca2+/calmodulin-dependent kinase type II (CaMKII).	Sci Rep, 2023, 13(1):5827 Elife, 2022, 11e74519 Front Physiol, 2021, 12:736920
F0342^New	Phospho-CaMKII (Thr286) Rabbit mAb	Calcium/calmodulin-dependent protein kinase type II subunit beta, Calcium/calmodulin-dependent protein kinase type II subunit delta, Calcium/calmodulin-dependent protein kinase type II subunit gamma, Calcium/calmodulin-dependent protein kinase type II subunit alpha, CaM kinase II subunit beta, CaMK-II subunit beta, CAMK2B, CAM2, CAMK2, CAMKB, CaM kinase II subunit delta; CaMK-II subunit delta, CAMK2D, CAMKD, CaM kinase II subunit gamma; CaMK-II subunit gamma, CAMK2G, CAMK, CAMK-II, CAMKG,CaM kinase II subunit alpha, CaMK-II subunit alpha, CAMK2A, CAMKA, KIAA0968, CaMK-II β, CaMK-II δ, CaMK-II γ, CaMK-II α
F1032	CaMKII Rabbit mAb	CaM Kinase II,CaMKII,CaMKII (pan),CaMKIIα/β/γ/δ
F0941^New	CaMKII-α Mouse mAb	CaMKII alpha,CaMKIIα,CaMKII-α
F0986^New	Calmodulin 1/2/3-C-terminal Rabbit mAb	Calmodulin,Calmodulin 1/2/3
E5833^New	KN-93 hydrochloride	KN-93 hydrochloride is a methoxybenzenesulfonamide derivative that inhibits Ca2+/calmodulin-dependent protein kinase II (CaMKII) with a Ki of 0.37 µM. It reduces dopamine (DA) production by influencing the reaction rate of tyrosine hydroxylase (TH), leading to decreased Ca(2+)-mediated phosphorylation of the TH protein.
E2202	1-Naphthyl PP1 hydrochloride	1-Naphthyl PP1 hydrochloride (1-NA-PP 1 hydrochloride) is a selective inhibitor of Src family kinases, inhibits v-Src, c-Fyn, c-Abl, CDK2 and CAMKII with IC50s of 1.0, 0.6, 0.6, 18 and 22 μM, respectively.
S6214	H-1152 dihydrochloride	H-1152 dihydrochloride (2HCl) is a membrane-permeable and selective inhibitor of Rho-associated protein kinase (ROCK). H-1152 inhibits ROCK2, PKA, PKC, PKG, AuroraA and CaMK2 with IC50 of 0.0120 μM, 3.03 μM, 5.68 μM, 0.360 μM, 0.745 μM and 0.180 μM, respectively.
S2642	1-Naphthyl PP1(1-NA-PP1)	1-Naphthyl PP1(1-NA-PP 1) is a highly selective and potent pan-PKD inhibitor with IC50 of 154.6 nM,133.4 nM and 109.4 nM for PKD1, PKD2 and PKD3, respectively. 1-Naphthyl PP1 is a selective inhibitor of Src family kinases (v-Src, c-Fyn) and the tyrosine kinase c-Abl with IC50 of 1.0 μM, 0.6 μM, 0.6 μM, 18 μM and 22 μM for v-Src, c-Fyn, c-Abl, CDK2 and CAMK II, respectively.	Cancer Gene Ther, 2025, 10.1038/s41417-025-00874-z
S6383	1-NM-PP1	1-NM-PP1 (PP1 Analog II, 1NM-PP1, analogue 9) is a potent inhibitor of Src family kinases with IC50 of 4.3 nM and 3.2 nM for v-Src-as1 and c-Fyn-as1, respectively. 1-NM-PP1 also inhibits CDK2-as1, CAMKII-as1 and c-Abl-as2 with IC50 of 5.0 nM, 8.0 nM and 120 nM, respectively.	J Cell Biol, 2024, 223(11)e202403165
S6221	Methyl cinnamate	Methyl cinnamate, an active component of Zanthoxylum armatum, is a widely used natural flavor compound with antimicrobial and tyrosinase inhibitor activities. Methyl Cinnamate Inhibits Adipocyte Differentiation via Activation of the CaMKK2--AMPK Pathway in 3T3-L1 Preadipocytes.
S3609	Berbamine dihydrochloride	Berbamine (BA, BBM) dihydrochloride, a traditional Chinese medicines extracted from Berberis amurensis (xiaoboan), is a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity and also an inhibitor of NF-κB. Berbamine (BA, BBM) dihydrochloride induces apoptosis in human myeloma cells and inhibits the growth of cancer cells by targeting Ca²⁺/calmodulin-dependent protein kinase II (CaMKII).	iScience, 2024, 27(10):110862 Eur J Pharmacol, 2024, S0014-2999(24)00322-4
S1421	Staurosporine (STS)	Staurosporine (STS) is a potent PKC inhibitor for PKCα, PKCγ and PKCη with IC50 of 2 nM, 5 nM and 4 nM, less potent to PKCδ (20 nM), PKCε (73 nM) and little active to PKCζ (1086 nM) in cell-free assays. Also shows inhibitory activities on other kinases, such as PKA, PKG, S6K, CaMKII, etc. Phase 3.	Cell Metab, 2025, S1550-4131(25)00149-4 Genes Dis, 2025, 12(3):101321 Cells, 2025, 14(6)450
S7423	KN-93 Phosphate	KN-93 Phosphate is a potent and specific inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) with K_i of 0.37 μM, no remarkable inhibitory effects on APK, PKC, MLCK or Ca2+-PDE activities. KN-93 attenuates CaMKII-induced autophagy.This product is not soluble in saline. Please do not dissolve it in saline for administration.	Stem Cell Res Ther, 2025, 16(1):208 bioRxiv, 2025, 2025.03.20.644192 Eye Vis (Lond), 2024, 11(1):37
S6787	KN-93	KN-93 is a cell-permeable, reversible and competitive inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMK-II) with Ki of 2.58 μM at rabbit myocardial CaM kinase activity.	Acta Neuropathol Commun, 2025, 13(1):70 Nat Commun, 2024, 15(1):840 Nat Commun, 2024, 15(1):1300
S7422	KN-62	KN-62 is a potent and specific inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII) with Ki of 0.9 μM; also a non-competitive antagonist of the purinergic receptor P2RX7 (IC50 = 15 nM). It is selective for CaMKII relative to PKA, PKC and MLCK, but inhibits CaMKI and CaMKIV equally well, The Ki value of KN-62 for CaMK V is 0.8 μM.	Redox Biol, 2024, 75:103249 Int J Mol Sci, 2024, 25(8)4340 Cell Rep, 2023, 42(7):112696
S8274	STO-609	STO-609 is a specific inhibitor of the Ca2+/Calmodulin-dependent protein kinase kinase(CaM-KK) that inhibits the activities of recombinant CaM-KKα and CaM-KKβ isoforms, with Ki values of 80 and 15 ng/ml, respectively, and also inhibits their autophosphorylation activities. STO-609 inhibits AMPKK activity and inhibits autophagy.	Redox Rep, 2025, 30(1):2447721 Cell Genom, 2025, 5(3):100782 Acta Pharm Sin B, 2024, 14(8):3576-3590
S7188	CID755673	CID755673 is a cell-active pan-PKD1/2/3 inhibitor with IC50 of 180 nM, 280nM, and 227 nM, respectively, about 200-fold selectivity over other CAMKs.	J Thromb Haemost, 2024, S1538-7836(24)00618-4 Nat Commun, 2023, 14(1):3543 Nat Commun, 2023, 14(1):3543
S7436	NH125	NH125 is a selective eEF-2 kinase inhibitor with IC50 of 60 nM, >125-fold selectivity over PKC, PKA, and CaMKII, and also a potent histidine kinase inhibitor.	Acta Pharmacol Sin, 2018, 10.1038/s41401-018-0165-9 Drug Des Devel Ther, 2018, Drug Des Devel Ther BMC Cancer, 2016, 16(1):813
E5833^New	KN-93 hydrochloride	KN-93 hydrochloride is a methoxybenzenesulfonamide derivative that inhibits Ca2+/calmodulin-dependent protein kinase II (CaMKII) with a Ki of 0.37 µM. It reduces dopamine (DA) production by influencing the reaction rate of tyrosine hydroxylase (TH), leading to decreased Ca(2+)-mediated phosphorylation of the TH protein.
E2202	1-Naphthyl PP1 hydrochloride	1-Naphthyl PP1 hydrochloride (1-NA-PP 1 hydrochloride) is a selective inhibitor of Src family kinases, inhibits v-Src, c-Fyn, c-Abl, CDK2 and CAMKII with IC50s of 1.0, 0.6, 0.6, 18 and 22 μM, respectively.
S6214	H-1152 dihydrochloride	H-1152 dihydrochloride (2HCl) is a membrane-permeable and selective inhibitor of Rho-associated protein kinase (ROCK). H-1152 inhibits ROCK2, PKA, PKC, PKG, AuroraA and CaMK2 with IC50 of 0.0120 μM, 3.03 μM, 5.68 μM, 0.360 μM, 0.745 μM and 0.180 μM, respectively.
S2642	1-Naphthyl PP1(1-NA-PP1)	1-Naphthyl PP1(1-NA-PP 1) is a highly selective and potent pan-PKD inhibitor with IC50 of 154.6 nM,133.4 nM and 109.4 nM for PKD1, PKD2 and PKD3, respectively. 1-Naphthyl PP1 is a selective inhibitor of Src family kinases (v-Src, c-Fyn) and the tyrosine kinase c-Abl with IC50 of 1.0 μM, 0.6 μM, 0.6 μM, 18 μM and 22 μM for v-Src, c-Fyn, c-Abl, CDK2 and CAMK II, respectively.	Cancer Gene Ther, 2025, 10.1038/s41417-025-00874-z
S6383	1-NM-PP1	1-NM-PP1 (PP1 Analog II, 1NM-PP1, analogue 9) is a potent inhibitor of Src family kinases with IC50 of 4.3 nM and 3.2 nM for v-Src-as1 and c-Fyn-as1, respectively. 1-NM-PP1 also inhibits CDK2-as1, CAMKII-as1 and c-Abl-as2 with IC50 of 5.0 nM, 8.0 nM and 120 nM, respectively.	J Cell Biol, 2024, 223(11)e202403165
S6221	Methyl cinnamate	Methyl cinnamate, an active component of Zanthoxylum armatum, is a widely used natural flavor compound with antimicrobial and tyrosinase inhibitor activities. Methyl Cinnamate Inhibits Adipocyte Differentiation via Activation of the CaMKK2--AMPK Pathway in 3T3-L1 Preadipocytes.
S9141	Berbamine	Berbamine (BA), a traditional Chinese medicines extracted from Berberis amurensis (xiaoboan), is a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity and also an inhibitor of NF-κB. Berbamine (BA) induces apoptosis in human myeloma cells and inhibits the growth of cancer cells by targeting Ca²⁺/calmodulin-dependent protein kinase II (CaMKII).	Vet Res, 2025, 56(1):37 Vet Microbiol, 2025, 301:110356 iScience, 2024, 27(10):110862
S3609	Berbamine dihydrochloride	Berbamine (BA, BBM) dihydrochloride, a traditional Chinese medicines extracted from Berberis amurensis (xiaoboan), is a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity and also an inhibitor of NF-κB. Berbamine (BA, BBM) dihydrochloride induces apoptosis in human myeloma cells and inhibits the growth of cancer cells by targeting Ca²⁺/calmodulin-dependent protein kinase II (CaMKII).	iScience, 2024, 27(10):110862 Eur J Pharmacol, 2024, S0014-2999(24)00322-4
F0342^New	Phospho-CaMKII (Thr286) Rabbit mAb	Calcium/calmodulin-dependent protein kinase type II subunit beta, Calcium/calmodulin-dependent protein kinase type II subunit delta, Calcium/calmodulin-dependent protein kinase type II subunit gamma, Calcium/calmodulin-dependent protein kinase type II subunit alpha, CaM kinase II subunit beta, CaMK-II subunit beta, CAMK2B, CAM2, CAMK2, CAMKB, CaM kinase II subunit delta; CaMK-II subunit delta, CAMK2D, CAMKD, CaM kinase II subunit gamma; CaMK-II subunit gamma, CAMK2G, CAMK, CAMK-II, CAMKG,CaM kinase II subunit alpha, CaMK-II subunit alpha, CAMK2A, CAMKA, KIAA0968, CaMK-II β, CaMK-II δ, CaMK-II γ, CaMK-II α
F0941^New	CaMKII-α Mouse mAb	CaMKII alpha,CaMKIIα,CaMKII-α
F0986^New	Calmodulin 1/2/3-C-terminal Rabbit mAb	Calmodulin,Calmodulin 1/2/3
E5833^New	KN-93 hydrochloride	KN-93 hydrochloride is a methoxybenzenesulfonamide derivative that inhibits Ca2+/calmodulin-dependent protein kinase II (CaMKII) with a Ki of 0.37 µM. It reduces dopamine (DA) production by influencing the reaction rate of tyrosine hydroxylase (TH), leading to decreased Ca(2+)-mediated phosphorylation of the TH protein.

Choose Selective CaMK Inhibitors